In this regard, Lee et al. [33], have indicated that the higher expression of lncRNA ANRIL is associated with higher drug resistance against Cisplatin and Doxorubicin in osteosarcoma cell lines. Here, CDKN2B-AS1 is linked to osteosarcoma.